MyEleanor

News

An artificial intelligence-based tool has shown impressive results in raising colorectal cancer screening rates in underserved populations.

Digital

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.

Sales & Marketing

The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.